Skip to main content
SpringerLink
Log in

Hereditary Cancer

  • Chapter
The Molecular Basis of Human Cancer

  • 240 Accesses

Abstract

The purpose of this chapter is to provide a clearer understanding of contemporary problems in the field of hereditary cancer, particularly as they relate to mortality, and with the ultimate goals of stimulating needed research and of improving patient care. This will be done both by discussing general principles that apply to all hereditary cancers and by showing specific examples. There are several previous reviews (1–4) to which the reader is referred for detailed descriptions and discussions of specific hereditary-cancer syndromes. However, because the field is changing rapidly, one of the more reliable and comprehensive sources for accurate and current information on specific hereditary-cancer syndromes is the Internet (see the Online Mendelian Inheritance in Man at http://www.hgmp.mrc.ac.uk/omim/index.html).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 159.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 209.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Similar content being viewed by others

References

  1. Lynch, H. T., Boman, B. M., and Lynch, J. F. (1993) Familial predisposition on malignancy. In: Medical Oncology ( Calabresi, P. and Schein, P., eds.), McGraw-Hill, New York, pp 121–142.

    Google Scholar 

  2. Burt, R. W. (1996) Familial risk and colorectal cancer. Gastroenterol. Clin. North Am. 25: 793–803.

    Article  PubMed  CAS  Google Scholar 

  3. Fearon, E. R. (1997) Human cancer syndromes: ‘clues to the origin and nature of cancer. Science 278: 1043–1050.

    Article  PubMed  CAS  Google Scholar 

  4. Kinzler, K. W. and Vogelstein, B. (1998) The Genetic Basis of Human Cancer(Kinzler, K. W., and Vogelstein, B., eds.), McGraw-Hill, New York, pp. 241–242.

    Google Scholar 

  5. Spirio, L., Olschwang, S., Groden, J., Robertson, M., Samowitz, W., Joslyn, G., et al. (1993) Alleles oftheAPCGene: an attenuated form of familial polyposis. Cell 75: 951–957.

    Article  PubMed  CAS  Google Scholar 

  6. van der Luijt, R. B., Meera Khan, P., Vasen, H. F., Breukel, C., Tops, C. M., Scott, R. J., et al. (1996) Germline mutations in the 3 part of APC exon 15 do not result in truncated proteins and are associated with attenuated adenomatous polyposis coli. Human Genet. 98: 727–734.

    Article  Google Scholar 

  7. Soravia, C., Berk, T., Madlensky, L., Mitri, A., Cheng, H., Gallinger, S., et al. (1998) Genotype-Phenotype correlations in attenuated adenomatous polyposis coli. Am. J. Human Genet. 62: 1290–1301.

    Article  CAS  Google Scholar 

  8. Kinzler, K. W. and Vogelstein, B. (1998) Colorectal tumors. In: The Genetic Basis of Human Cancer (Kinzler, K. W., and Vogelstein, B., eds.), McGraw-Hill, New York, pp. 565–587.

    Google Scholar 

  9. Dietrich, W. F., Lander, E. S., Smith, J. S., Moser, A. R., Gould, K. A., Luongo, C., et al. (1993) Genetic identification of Mom-1, a major modifier locus affecting Min-induced intestinal neoplasia in the mouse. Cell 75: 631–639.

    Article  PubMed  CAS  Google Scholar 

  10. MacPhee, M. Chepnik, K. P., Liddell, R. A., Nelson, K. K., Siracusa (1996) Suppression of intestinal polyposis in APC delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell 87: 803–809.

    Google Scholar 

  11. Powell, S. M., Petersen, G. M., Krush, A. J., Booker, S., Jen, J., Giardiello, F. M., et al. (1993) Molecular diagnosis of familial adenornatous polyposis. N. Engl. J. Med. 329: 1982–1987.

    Article  PubMed  CAS  Google Scholar 

  12. Dragani, T. A. and Maneti, G. (1997) Mom-1 leads the pack. Nature Genet. 17: 7–8.

    Article  PubMed  CAS  Google Scholar 

  13. Laird, P. W., Jackson-Grusby, L., Fazeli, A., Dickinson, S. L., Jung, W. E., Li, B., et al. (1995) Suppression of intestinal neoplasia by DNA hypomethylation. Cell 81: 197–205.

    Article  PubMed  CAS  Google Scholar 

  14. Oshima, M., Dinchuk, J. E., Kargman, S. L., Oshima, H., Hancock, B., Kwong, E., et al. (1996) Suppression of intestinal polyposis in APC delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell 87: 803–809.

    Article  PubMed  CAS  Google Scholar 

  15. Huang, J., Papadopoulos, N., McKinley, A. J., Farrington, S. M., Curtis, L. J., Wyllie, A. H., et al. (1996)APCmutations in colorectal tumors with mismatch repair deficiency. Proc. Natl. Acad. Sci. USA 93: 9049–9054.

    Google Scholar 

  16. Markowitz, S., Wang, J., Myeroff, L., Parsons, R., Sun, L., Lutterbaugh, J., et al. (1995) Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability. Science 268: 1336–1338.

    Article  PubMed  CAS  Google Scholar 

  17. Holtzman, L. D., and Buchberg, A. M. (1995) The secretory phospholipase A2 gene is a candidate for the Mom-1 locus, a major modifier of APCMin-induced intestinal neoplasia. Cell 81: 957–966.

    Article  Google Scholar 

  18. Cormier, R. T., Hong, K. H., Halberg, R. B., Hawkins, T. L., Richardson, P., Mulherkar, R., et al. (1997) Secretory phospholipase Pla2g2a confers resistance to intestinal tumorigenesis. Nature Genet. 17: 88–89.

    Article  PubMed  CAS  Google Scholar 

  19. FitzGerald, M. G., Bean, J. M., Hegde, S. R., Unsal, H., MacDonald, J., Harkin, P. D., et al. (1997) Heterozygous ATM mutations do not contribute to early onset of breast cancer. Nature Genet. 15: 307–310.

    Article  PubMed  CAS  Google Scholar 

  20. Miyoshi, Y., Nagase, H., Ando, H., Horii, A., Ichii, S., Nakatsuru, S., et al. (1993) Association of the APC tumor suppressor protein with catenins. Science 262: 1734–1737.

    Article  Google Scholar 

  21. Rubinfeld, B., Souza, B., Albert, I., Muller, O., Chamberlain, S., Masiarz, F., et al. (1993) Association of the APC gene product with (3-catenin. Science 262: 1731–1734.

    Article  PubMed  CAS  Google Scholar 

  22. Munemitsu, S., Souza, B., Muller, O., Albert, 1., Rubinfeld, B., Polakis, P. (1994) The APC gene product associates with microtubules in vivo and promotes their assembly in vitro. Cancer Res. 54: 3676–3681.

    PubMed  CAS  Google Scholar 

  23. Smith, K. J., Levy, D. B., Maupin, P., Pollard, T. D., Vogelstein, B., Kinzler, K. W. (1994) Wild-type but not mutant APC associates with the microtubule cytoskeleton. Cancer Res. 54: 3672–3675.

    PubMed  CAS  Google Scholar 

  24. Gao, Z. Q., Gao, Z. P., Bhattacharya, G., Wang, L. J., Wu, J. M., and Boman. B. M. (1998) APC’s basic domain in its carboxyl region mediates tubulin polymerization in vitro. Proc. Am. Assoc. Cancer Res. 39: 616a.

    Google Scholar 

  25. Lynch, H. T. (1996) Glossary of key terms. Oncology 10: 39–40.

    PubMed  CAS  Google Scholar 

  26. Thompson, J. S. and Thompson, M. W. (1973) Genetics in Medicine, 2nd ed. W.B. Saunders and Co., Philadelphia, PA.

    Google Scholar 

  27. Knudson, A. G. (1971) Mutation and cancer: statistical study of retinoblastoma. Proc. Natl. Acad. Sci. USA 68: 820–823.

    Article  PubMed  Google Scholar 

  28. Knudson, A. G. (1978) Retinoblastoma: a prototypic hereditary neoplasm. Semin. Oncol. 5: 57–60.

    PubMed  Google Scholar 

  29. Fearon, E. R. and Vogelstein, B. (1990) A genetic model for colorectal tumorigenesis. Cell 61: 759–767.

    Article  PubMed  CAS  Google Scholar 

  30. Smith, H. D., Lu, Y., Deng, G., Martinez, O., Krams, S., Ljung, B. M., et al. (1993) Molecular aspects of early stages of breast cancer progression. J. Cell. Biochem. 17C: 144–152.

    Article  Google Scholar 

  31. Knudson, A. G. (1993) All in the (cancer) family. Nature Genet. 5: 103–104.

    Article  PubMed  CAS  Google Scholar 

  32. King, R. C. and Standsfield, W. D. (1997)A Dictionary ofGenetics,5th ed. Oxford University Press, New York, NY.

    Google Scholar 

  33. Miki, Y., Swensew, J., Shattuck-Eidens, D., Futreal, A., Harshman, K., Tavtigian, S., et. al. (1994) A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266: 66–71.

    Article  PubMed  CAS  Google Scholar 

  34. Wooster, R., Bignell, G., Lancaster, J., Swift, S., Seal, S., Mangion, J., et al. (1995) Identification of the breast cancer susceptibility gene BRCA2. Nature 378: 789–792.

    Article  PubMed  CAS  Google Scholar 

  35. Tavtigian, S. V., Simard, J., Romens, J., Couch, F., ShattuckEidens, D., Neuhausen, S., et al. (1996) The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds Nature Genet. 12: 333–337.

    Article  PubMed  CAS  Google Scholar 

  36. Lu, S.-L., Kawabata, M., Imamura, T., Akiyama, Y., Nomizu, T., Miyazono, K., et al. (1998) HNPCC associated with germline mutation in the TGF-beta type II receptor gene. Nature Genetics 19: 17–18.

    Article  PubMed  CAS  Google Scholar 

  37. Offit, K. (1998) Hereditary and acquired risks for cancer. In: Clinical Cancer Genetics: Risk Counseling and Management. Wiley-Liss, New York, NY.

    Google Scholar 

  38. Lynch, H. T., Drouhard, T., Vasen, H. F. A., Cavalieri, J., Lynch, J., Nord, S., et al. (1996) Genetic counseling in a Navajo Hereditary nonpolyposis colorectal cancer kindred. Cancer 77: 30–35.

    Article  PubMed  CAS  Google Scholar 

  39. Powell, S. M., Petersen, G. M., Krush, A. J., Booker, S., Jen, J., Giardiello, F. M., et al. (1993) Molecular diagnosis of familial adenornatous polyposis. N. Engl. J. Med. 329: 1982–1987.

    Article  PubMed  CAS  Google Scholar 

  40. Hogervorst, F. B. L. (1997) The Protein Truncation Test (PTT). Promega Notes 62: 7–10.

    Google Scholar 

  41. Laken, S. J., Petersen, G. M., Gruber, S. B., Oddoux, C., Ostrer, H., Giardiello, F. M., et al. (1997) Familial colorectal cancer in Ashkenazim due to a hypermutable tract in APC. Nature Genet. 17: 79–83.

    Article  PubMed  CAS  Google Scholar 

  42. Rozen, P., Shomrat, R., Strul, H., Naiman, T., Karminsky, N., Le-gum, C., et al. (1999) Prevalence of the 11307K APC gene variant in Israeli Jews of differing ethnic origin and risk for colorectal cancer. Gastroenterology 116: 54–57.

    Article  PubMed  CAS  Google Scholar 

  43. Prior, T. W., Chadwick, R. B., Papp, C., Arcot, A. N., Isa, A. M., Pearl, D. K., et al. (1999) The I1307K polymorphism of the APC gene in colorectal cancer. Gastroenterology 116: 58–63.

    Article  PubMed  CAS  Google Scholar 

  44. Gryfe, R., DiNicola, N., Gallinger, S., and Redston, M. (1998) Somatic instability of the APC 11307K allele in colorectal neoplasia. Cancer Res. 58: 4040–4043.

    PubMed  CAS  Google Scholar 

  45. Petersen, G. M., Parmigiani, G., and Thomas, D. (1998) Missense mutations in disease genes: A Bayesian approach to evaluate causality. Am. J. Human Genet. 62: 1516–1524.

    Article  CAS  Google Scholar 

  46. Redston, M., Nathanson, K. L., Yuan, Z. Q., Neuhausen, S. L., Satagopan, J., Wong, N., et al. (1998) The APC 11307K allele and breast cancer risk. Nature Genet. 20: 13–14.

    Article  PubMed  CAS  Google Scholar 

  47. Woodage, T., King, S. M., Wacholder, S., Hartge, P., Struewing, J. P., McAdams, M., et al. (1998) The APC 11307K allele and cancer risk in a community-based study of Ashkenazi Jews. Nature Genet. 20: 62–65.

    Article  PubMed  CAS  Google Scholar 

  48. Abrahamson, J., Mosiehi, R., Vesprini, D., Karlan, B., Fishman, D., Smotkin, D., et al. (1998) No association of the I 1 307K APC allele with ovarian cancer risk in Ashkenazi Jews. Cancer Res. 58: 2919–2922.

    PubMed  CAS  Google Scholar 

  49. Petrukhin, L., Dangel, J., Vanderveer, L., Costalas, J., Bellacosa, A., Grana, G., et al. (1997) The 11307K APC mutation does not predispose to colorectal cancer in Jewish Ashkenazi breast and breast-ovarian kindreds. Cancer Res. 57: 5840–5484.

    Google Scholar 

  50. Lothe, R. A., Hektoen, M., Johnsen, H., Meling, G. I., Andersen, T. I., Rognum, T. O., et al. (1998) The APC gene I1307K variant is rare in Norwegian patients with familial and sporadic colorectal or breast cancer. Cancer Res. 58: 2923–2924.

    PubMed  CAS  Google Scholar 

  51. Francke, U., Holmes, L. B., Atkins, L., and Riccardi, V. M. (1979) Aniridia-Wilms’ tumor association: Evidence for specific deletion of 11p13. Cytogenet. Cell Genet. 24: 185–192.

    Article  PubMed  CAS  Google Scholar 

  52. Riccardi, V. M., Wheeler, T. M., Pickard, L. R. and King, B. (1980) The pathophysiology of neurofibromatosis. II. Angiosarcoma as a complication. Cancer Genet. Cytogenetics 2: 275–280.

    Article  Google Scholar 

  53. Herrera, L., Kakati, S., Gibas, L., Pietrzak, E., and Sandberg, A. (1986) Gardner syndrome in a man with an interstitial deletion of 5q. Am. J. Med. Genet. 25: 473–476.

    Article  PubMed  CAS  Google Scholar 

  54. Fountain, J. W., Wallace, M. R., Bruce, M. A., Seizinger, B. R., Menon, A. G., Gusella, J. F., et al. (1989) Physical mapping of a translocation breakpoint in neurofibromatosis. Science 244: 1085–1087.

    Article  PubMed  CAS  Google Scholar 

  55. O’Connell, P., Leach, R., Cawthon, R. M., Culver, M., Stevens, J., Viskochil, D., et al. (1989) Two NE1 translocations map within a 600-kilobase segment of 17g11.2. Science 244: 1087–1088.

    Article  PubMed  Google Scholar 

  56. Wildrick, D. M. and Boman, B. M. (1988) Chromosome 5 allele loss at the glucocorticoid receptor locus in human colorectal carcinomas. Biochem. Biophys. Res. Commun. 150: 591–598.

    Article  PubMed  CAS  Google Scholar 

  57. Solomon, E., Voss, R., Hall, V., Bodmer, W. F., Jass, J. R., Jeffreys, A. J., et al. (1987) Chromosome 5 allele loss in human colorectal carcinomas. Nature 328: 616–619.

    Article  PubMed  CAS  Google Scholar 

  58. Mulligan, L. M., Kwok, J. B., Healey C. S., Elsdon, M. J., Eng, C., Gardner, E., et al. (1993) Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia. Nature 363: 458–460.

    Article  PubMed  CAS  Google Scholar 

  59. Mulligan, L. M., Eng, C., Healey, C. S., Clayton, D., Kwok, J. B., Gardner, E., et al. (1994) Specific mutations of the RET proto-oncogene are related to disease phenotype in MEN 2A and FMTC. Nature Genet. 6: 70–74.

    Article  PubMed  CAS  Google Scholar 

  60. van Heyningen, V. (1994) Genetics. One gene four syndromes Nature 367: 319–320.

    Article  PubMed  Google Scholar 

  61. Eng, C. (1996) The RET proto-oncogene in multiple endocrine neoplasia type 2 and Hirschsprung’s disease. N. Engl. J. Med. 335: 943–951.

    Article  PubMed  CAS  Google Scholar 

  62. Eng, C. and Mulligan, L. M., (1997) Mutations of the RET proto-oncogene in the multiple endocrine neoplasia type 2 syndromes, related sporadic tumours, and Hirschprung disease. Human Mutat. 9: 97–109.

    Article  CAS  Google Scholar 

  63. Schmidt, L., Duh, F. M., Chen, F., Kishida, T., Glenn, G., Choyke, P., et al. (1997), Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas. Nature Genet. 16, 68–73.

    Article  PubMed  CAS  Google Scholar 

  64. Hemminki, A., Tomlinson, I., Markie, D., Jarvinen, H., Sistonen, P., Bjorkqvist, A. M., et al. (1997) Localization of a susceptibility locus for Peutz-Jeghers syndrome to 19p using comparative genomic hybridization and targeted linkage analysis. Nature Genet. 15: 87–90.

    Article  PubMed  CAS  Google Scholar 

  65. Hemminki, A., Markie, D., Tomlinson, I., Avizienyte, E., Roth, S., Loukola, A., et al. (1998) A serine/threonine kinase gene defective in Peutz-Jeghers syndrome. Nature 391: 184–187.

    Article  PubMed  CAS  Google Scholar 

  66. Jenne, D. E., Reimann, H., Nezu, J., Friedel, W., Loff, S., Jeschke, R., et al. (1998) Peutz-Jeghers syndrome is caused by mutations in a novel serine threonine kinase. Nature Genet. 18: 38–43.

    Article  PubMed  CAS  Google Scholar 

  67. Marra, G. and Boland, C. R. (1995) Hereditary nonpolyposis colorectal cancer: the syndrome, the genes, and historical perspectives. J. Natl. Cancer Inst. 87: 1114–1125.

    Article  PubMed  CAS  Google Scholar 

  68. Kinzler, K. W. and Vogelstein, B. (1996) Lessons from hereditary colorectal cancer. Cell 87: 159–170.

    Article  PubMed  CAS  Google Scholar 

  69. Muto, M. G., Cramer, D. W., Tangir, J., eBerkowitz, R., and Mok, S. (1996) Frequency of the BRCA1 de1185Ag mutation among Jewish women with OVCA and matched populations controls. Cancer Res. 56: 1250–1252.

    PubMed  CAS  Google Scholar 

  70. Abeliovich, D., Kaduri, L., Lerer, I., Weinberg, N., Amir, G., Sagi, M., et al. (1997) Founder mutations 185delAG and 5382insC in BRCA1 and 6174delT in BRCA2 appear in 60% of Ovarian cancer and 30% of early-onset breast cancer patients among Ashkenazi Jewish women. Am. J. Human Genet. 60: 505–514.

    CAS  Google Scholar 

  71. Struewing, J. P., Hartge, P., Wacholder, S., Baker, S. M., Berlin, M., McAdams, M., et al. (1997) The risk of cancer associated with specific mutations of BRCA 1 and BRCA2 amongst Ashkenazi Jews. N. Engl. J. Med. 336: 1401–1408.

    Article  PubMed  CAS  Google Scholar 

  72. FitzGerald, M. G., MacDonald, D. J., Krainer, M., Hoover, I., O’Neil, E., Unsal, H., et al. (1996) Germ-line BRCA1 mutations in Jewish and non-Jewish women with early onset breast cancer. N. Engl. J. Med. 334: 143–149.

    Article  PubMed  CAS  Google Scholar 

  73. Frank, T. S., Manley, S. A., and Olufunmilayo, O. I., (1998) Sequence analysis ofBRCA1 and BRCA2: Correlation ofmutations with family history and ovarian cancer risk. J Clin. Oncol. 16: 2417–2425.

    PubMed  CAS  Google Scholar 

  74. Wertz, D. C. (1994) Genetic testing for children and adolescents: Who decides? JAMA 272: 875–881.

    Article  PubMed  CAS  Google Scholar 

  75. Cotton, R. (1993) Current methods of mutation detection. Mutation Res. 285: 125–144.

    Article  PubMed  CAS  Google Scholar 

  76. Cotton, R. G. H. (1996) Detection of unknown mutations in DNA: a catch-22. Am. J. Human Genet. 59: 289–291.

    CAS  Google Scholar 

  77. Dianzani, I., Camaschella, C., Ponzone, A., and Cotton, R. G. H. (1993) Dilemmas and progress in mutation detection. Trends Genet. 9: 403–405.

    Article  PubMed  CAS  Google Scholar 

  78. Forrest, S., Cotton, R., Landegren, U. and Southern, E. (1996) How to find all those mutations. Nature Genet. 10: 375–376.

    Article  Google Scholar 

  79. Anonymous (1996) Statement of the American Society of Clinical Oncology: genetic testing for cancer susceptibility. J. Clin. Oncol. 14: 1730–1739.

    Google Scholar 

  80. Giardiello, F. M. (1997) Genetic testing in hereditary colorectal cancer. JAMA 278: 1278–1281.

    Article  PubMed  CAS  Google Scholar 

  81. Boman, B. M. and Levin, B. (1986) Familial polyposis. Hosp. Pract. 21: 155–170.

    CAS  Google Scholar 

  82. Lynch, H. T., Watson, P., Smyrk, T. C., Lanspa, S. J., Boman, B. M., Boland, C. R., et al. (1992) Colon cancer genetics. Cancer 70: 1300–1312.

    Google Scholar 

  83. Liu, B., Farrington, S. M., Petersen, G. M., Hamilton, S. R., Parsons, R., Papdopoulos, N., et al. (1995) Genetic instability occurs in the majority of young patients with colorectal cancer. Nature Med. 1: 348–352.

    Article  PubMed  CAS  Google Scholar 

  84. Vasen, H. F. A., Mecklin, J. P.1., Meera Khan, P., and Lynch, H. T. (1991) The International Collaborative Group on Hereditary Nonpolyposis Colorectal Cancer. Dis. Colon Rectum 34: 424–425.

    Article  PubMed  CAS  Google Scholar 

  85. Vasen, H. F. A., Mecklin, J. P., Meera Khan, P., and Lynch, H. T. (1994) The International Collaborative Group on Hereditary Nonpolyposis Colorectal Cancer. Anticancer Res. 14: 1661–1664.

    PubMed  CAS  Google Scholar 

  86. Vasen, H. F., Watson, P., Mecklin, J. P., and Lynch, H. T. (1999) New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative Group on HNPCC. Gastroenterology 116: 1453–1456.

    Article  PubMed  CAS  Google Scholar 

  87. Rodriguez-Bigas, M. A., Boland, C. R., Hamilton, S. R., Henson, D. E., Jass, J. R., Khan, P. M., et al. (1997) A national cancer institute workshop on hereditary nonpolyposis colorectal cancer syndrome: Meeting highlights and Bethesda guidelines. J. Natl. Cancer Inst. 89: 1758–1762.

    Article  PubMed  CAS  Google Scholar 

  88. Wijnen, J., Khan, M. P., Vasen, H., van der Klift, H., Mulder, A., van Leeuwen-Coornelisse, I., et al. (1997) Hereditary nonpolyposis colorectal cancer families not complying with the Amsterdam criteria show high frequency of mismatch-repair-gene mutations. Am. J. Human Genet. 61: 329–335.

    Article  CAS  Google Scholar 

  89. Lynch, H. T., Watson, P. A., Franklin, A., Smith, S., Tinley, S., Lynch, J., et al. (1998) Molecular genetics and genetic counseling in HNPCC (Lynch syndromes). Proc. Am. Soc. Clin. Oncol. 17: 547a.

    Google Scholar 

  90. Dietmaier, W., Wallinger, S., Bocker, T., Jullmann, F., Fishel, R., and Rüschoff, J. (1997) Diagnostic microsatellite instability: Definition and correlation with mismatch repair protein expression. Cancer Res. 57: 4749–4756.

    PubMed  CAS  Google Scholar 

  91. Boland, C. R., Thibodeau, S. N., Hamilton, S. R., Sidransky, D., Eshleman, J. R., Burt, R. W., et al. (1998) National Cancer Institute workshop on microsatellite instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res. 71: 5248–5257.

    Google Scholar 

  92. Konishi, M., Kikuchi-Yanoshita, R., Tanaka, K., Muraoka, M., Onda, A., Okumura, Y., et al. (1996) Molecular nature of colon tumors in hereditary nonpolyposis colon cancer, familial polyposis, and sporadic colon cancer. Gastroenterology 111: 307–317.

    Article  PubMed  CAS  Google Scholar 

  93. Bocker, T., Diermann, J., Fried], W., Gebert, J., Holinski-Feder, E., Karner-Hanusch, J., et al. (1997) Microsatellite instability analysis: a multicenter study for reliability and quality control. Cancer Res. 57: 4739–4743.

    PubMed  CAS  Google Scholar 

  94. Boland C. R. (1998) Hereditary nonpolyposis colorectal cancer. In: The Genetic Basis of Human Cancer ( Kinzler, K. W. and Vogelstein, B., eds.), McGraw-Hill, New York, NY, pp. 333–346.

    Google Scholar 

  95. Aaltonen, L. A., Salovaara, R., Kristo, P., Canzian, F., Hemminki, A., Peltomaki, P., et al. (1998) Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease. N. Engl. J Med. 338: 1481–1487.

    Article  PubMed  CAS  Google Scholar 

  96. Bailar, III, J. C. and Gornik, H. L. (1997) Cancer undefeated. N. Engl. J. Med. 336: 1569–1574.

    Article  PubMed  Google Scholar 

  97. Genuardi, M., Anti, M., Capozzi, E., Leonardi, F., Fornasarig, M., Novella, E., et al. (1998) MLHI andMSH2 constitutional mutations in colorectal cancer families not meeting the standard criteria for hereditary nonpolyposis colorectal cancer. Int. J. Cancer. 75: 835–839.

    Article  PubMed  CAS  Google Scholar 

  98. Boman, B. M., Fant, G., Fields, J. Z., Lynch, H. T., Watson, P. A. (1998) Improving the detection of hereditary nonpolyposis cancer. Proc. Am. Soc. Clin. Oncol. 17: 561a.

    Google Scholar 

  99. Percesepe, A., Anti, M., Roncucci, L., Armelao, F., Marra, G., Pahor, M., et al. (1995) The effect of family size on estimates of the frequency of hereditary non-polyposis colorectal cancer. Br. J. Cancer 72: 1320–1323.

    Article  PubMed  CAS  Google Scholar 

  100. Hall, N. R., Finan, P. J., Ward, B., Turner, G., and Bishop, D. T. (1994) Genetic susceptibility to colorectal cancer in patients under 45 years of age. Br. J. Surg. 81: 1485–1489.

    Article  PubMed  CAS  Google Scholar 

  101. Liu, B., Nicolaides, N. C., Markowitz, S., Willson, J. K., Parsons, R. E., Jen, J., et al. (1995) Mismatch repair gene defects in sporadic colorectal cancers with microsatellite instability. Nature Genet. 9: 48–55.

    Article  PubMed  CAS  Google Scholar 

  102. Fante, R., Bennatti, P., di Gregorio, C., De Pietri, S., Pedroni, M., Tamassia, M. G., et al. (1997) Colorectal carcinoma in different age groups: a population-based investigation. Am. J. Gastroenterol. 92: 1505–1509.

    PubMed  CAS  Google Scholar 

  103. Syngal, S., Fox, E. A., Li, C., Dovidio, M., Eng, C., Kolodner, R. D., et al. (1999) Interpretation of genetic test results for hereditary nonpolyposis colorectal cancer: Implications for clinical predisposition testing. JAMA 282: 247–253.

    Article  PubMed  CAS  Google Scholar 

  104. Aarino, M., Mecklin, J. P., Aaltonen, L. A., et al. (1995) Lifetime risk of different cancers in hereditary nonpolyposis colon cancer (HNPCC) syndrome. Int. J. Cancer 64: 430–433.

    Article  Google Scholar 

  105. Bulow, S. (1987) Familial polyposis coli. Dan. Med. Bull. 34: 1–15.

    PubMed  CAS  Google Scholar 

  106. Alm, T. and Licznerski, G. (1973) The intestinal polyposis. Clin. Gastroenterol. 2: 577–602.

    Google Scholar 

  107. Bussey, H. J. R. (1975) Familial Polyposis Coli. The John Hopkins University Press, Baltimore, MD.

    Google Scholar 

  108. Arvantis M. L., Jagelman, D. G., Fazio, V. W., Lavery, I. C. and McGannon, E. (1990) Mortality in patients with familial adenomatous polyposis. Dis. Colon Rectum. 33: 639–642.

    Article  Google Scholar 

  109. Gutmann, D. H. and Collins F. S. (1998) Neurofibromatosis type 1. In: The Genetic Basis of Human Cancer ( Kinzler. K. W., and Vogelstein, B., eds.), McGraw-Hill, New York, pp. 423–442.

    Google Scholar 

  110. MacCollin, M. and Gusella, J. (1998) Neurofibromatosis type 2. In: The Genetic Basis of Human Cancer ( Kinzler, K. W., and Vogelstein, B., eds.), McGraw-Hill, New York, pp. 443–453.

    Google Scholar 

  111. Carlson, K. M., Bracamontes, J., Jackson, C. E., Clark, R., Lacroix, A., Wells, S. A., et al. (1994) Parent-of-origin effects in multiple endocrine neoplasia type 2B. Am. J. Human Genet. 55: 1076–1082.

    CAS  Google Scholar 

  112. Ponder, B. (1997) Genetic testing for cancer risk. Science 278: 1050–1054.

    Article  PubMed  CAS  Google Scholar 

  113. Hubbard, R. and Lewontin, R. C. (1996) Pitfalls of genetic testing. N. Engl. J. Med. 334: 1192–1193.

    Article  PubMed  CAS  Google Scholar 

  114. Shattuck-Eidens, D. S., Oliphant, A., McClure, M., McBride, C., Gupte, J., Rubano, T., et al. (1997) BRCAI sequence analysis in women at high risk for susceptibility mutations: Risk factor analysis and implications for genetic testing. JAMA 278: 1242–1250.

    CAS  Google Scholar 

  115. Schrag, D., Kuntz, K.M., Garber, J.E. and Wecki, J.C. (2000) Life expectancy gains from cancer prevention strategies for women with breast cancer and BRCA1 or BRCA2 mutations. JAMA 283: 617–624.

    Google Scholar 

  116. Hartman, L.C., Schaid, D.J., Woods, J.E., Crotty, T.P., Myers, J.L., Arnold, P.G., Petty, P.M., Sellers, T.A., Johnson, J.L., McDonnell, S.K., Frost, M.H. and Jenkins, R.B. (1999) Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer. N. Engl. J. Med. 340: 77–84.

    Article  Google Scholar 

  117. Rebbeck, T.R., Levin, A.M., Eisen, A., Snyder, C., Watson, P., Cannon-Albright, L., Isaacs, C., Olopade, O., Garber. J.E., Godwin, A.K., Oaly, M.B., Narod, S.A., Neuhausen, S.L., Lynch, H.T. and Weber, B.L. (1999) Breast cancer risk after bilateral prophylactic oophorectomy in BRCA1 mutation carriers. J. Natl. Cancer Inst. 91: 1475–1479.

    CAS  Google Scholar 

  118. Grann, V.R., Jocobsen, J.S., Whang, W., Hershman, D., Heitjen, D.F., Antman, K.H. and Neugut, A.1. (2000) Prevention with tamoxifen or other hormones versus prophylactic surgery in BRCA.1/2 positive women: A decision analysis. Cancer J. Sci. Am. 6: 13–20.

    PubMed  CAS  Google Scholar 

  119. Lynch, H.T. and Casey, M.J. (2001) Current status of prophylactic surgery for hereditary breast and gynecologic cancers. Curr. Opin. Obste’. Gynecol. 13: 25–30.

    Article  CAS  Google Scholar 

  120. Marcus, J. N., Page, D. L., Watson, P., Narod, S. A., Lenoir, G. M. and Lynch, H. T. (1997) BRCA I and BRCA2 hereditary breast carcinoma phenotypes. Cancer 80: 543–556.

    Google Scholar 

  121. Burke W., Daly, M., Garber, J., Botkin, J., Kahn, M. J., Lynch, P., et al. (1997) Recommendations for follow-up care of individuals with an inherited predisposition to cancer. II. BRCA1 and BRCA2. Cancer genetics Studies Consortium. JAMA 277: 997–1003.

    Article  PubMed  CAS  Google Scholar 

  122. Lerman, C. and Croyle, R. T. (1996) Emotional and behavioral responses to genetic testing for susceptibility to cancer. Oncology 10: 191–199.

    PubMed  CAS  Google Scholar 

  123. Spigelman, A. D. and Thomson, J. P. S. (1994) Introduction, history and registries. In: Familial Adenomatous Polyposis and Other Polyposis Syndromes (Phillips, R. K. S., ed.), Arnold, London, UK, pp. 3-14.

    Google Scholar 

  124. Järvinen, H. J., Aarino, M., Mustonen, H., Aktan-Collab, K., Aaltonen, L.A., Peltonaki, P., de la Chapelle, A., Mecklin, J.P. (2000) Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer. Gastroenterology 118: 829–834.

    Article  PubMed  Google Scholar 

  125. Winawer, S., Zauber, A. G., O’Brien, M. J., Ho, M. N., Gottlieb, L., Sternberg, S. S., et al. (1993) National Polyp Study Workgroup. Randomized comparison of surveillance intervals after colonoscopic removal of newly diagnosed adenomatous polyps. N. Engl. J. Med. 328: 901–906.

    Article  PubMed  CAS  Google Scholar 

  126. Vasen, H. F. A., den Hartog Jager, F. C. A., Menko, F. H., and Nagengast, F. M. (1989) Screening for hereditary non-polyposis colorectal cancer: a study of 22 kindreds in The Netherlands. Am. J. Med. 86: 278–281.

    Article  PubMed  CAS  Google Scholar 

  127. Lynch, H. T. and Smyrk, T. (1996) Hereditary nonpolyposis colorectal cancer (Lynch Syndrome). Cancer 78: 1149–1167.

    Article  PubMed  CAS  Google Scholar 

  128. Giardiello, F. M., Brensinger, J. D., Petersen, G. M., Luce, M. D., Hylind, L. M., Bacon, J. A., et al. (1997) The use and interpretation of commercial APC gene testing for familial adenomatous polyposis. N. Engl. J. Med. 336: 823–827.

    Article  PubMed  CAS  Google Scholar 

  129. Stephenson, J. (1998) Group drafts core curriculum for `What does need to know about genetics.’ JAMA 279: 735–736.

    Article  PubMed  CAS  Google Scholar 

  130. Lemon, S. J., Tinley, S. T., Fusaro, R. M., and Lynch, H. T. (1997) Cancer risk assessment in a hereditary cancer prevention clinic and its first year’s experience. Cancer 80: 606–613.

    Article  Google Scholar 

  131. Lynch, H. T. and Lynch, J. (1996) Genetic counseling for hereditary cancer. Oncology 10: 27–34.

    PubMed  CAS  Google Scholar 

  132. Menko, F. H., Wijnen, J. T., Khan, P. M., Vasen, H. F. A., and Oostcrwijk, M. H. (1996) Genetic counseling in hereditary nonpolyposis colorectal cancer. Oncology 10: 71–82.

    PubMed  CAS  Google Scholar 

  133. American Society of Clinical Oncology (1998) Cancer Genetics Satellite Symposium on The Role of Genetics in Clinical Cancer Care, 34th Annual Meeting, Los Angeles CA, May 15, 1998.

    Google Scholar 

  134. Peters, J. A. and Stopfer, J. E. (1996) Role of the genetic counselor in familial cancer. Oncology 10: 159–175.

    PubMed  CAS  Google Scholar 

  135. Petersen, G. M. and Brensinger, J. D. (1996) Genetic testing and counseling in familial adenomatous polyposis. Oncology 10: 89–98.

    PubMed  CAS  Google Scholar 

  136. Lynch, P., Severin, M., Mills, A., Bosserman, L. Carson, D., Chamber, D. C., et al. (1997) Medical/legal issues in genetic testing: Workshop no. 3. Cancer 80: 630–631.

    Article  Google Scholar 

  137. Ruden, R. A. and Byalick, M. (1997) The Craving Brain. Harper-Collins, New York, NY.

    Google Scholar 

  138. Garber, J. (1999) A 40-year old woman with a strong family history of breast cancer. JAMA 282: 1953–1960.

    Article  PubMed  CAS  Google Scholar 

  139. Weber, T. K., Chin, H. M., Rodriguez-Bigas, M., Keitz, B., Gillagan, R., O’Malley, L., et al. (1999) Novel hMLH l and hMSH2 germline mutations in African Americans with colorectal cancer. JAMA 281: 2316–2320.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. Bruce M. Boman MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Lael Melchert MS
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jeremy Z. Fields PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Pathology and Laboratory Medicine, University of North Carolina School of Medicine, Chapel Hill, NC, USA

    William B. Coleman

  2. Department of Pathology and Laboratory Medicine, Hartford Hospital, Hartford, CT, USA

    Gregory J. Tsongalis

Rights and permissions

Reprints and permissions

Copyright information

© 2002 Springer Science+Business Media New York

About this chapter

Cite this chapter

Boman, B.M., Melchert, L., Fields, J.Z. (2002). Hereditary Cancer. In: Coleman, W.B., Tsongalis, G.J. (eds) The Molecular Basis of Human Cancer. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-125-1_8

Download citation

  • DOI: https://doi.org/10.1007/978-1-59259-125-1_8

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-61737-107-3

  • Online ISBN: 978-1-59259-125-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation